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Is the evidence for a link between cancer and
obesity now compelling?
I would say yes. I would say that there is sufficient evidence
to support a causal link between obesity and a number of
cancers.
So it’s not all cancers?
It’s not all cancers. For some cancers, the association has
been observed quite consistently in different studies and in
different populations. For other cancers, the association has
been - the results have been - less consistent. And possibly
there are quite a number of cancers that are simply not
associated with obesity.
So which are the cancers that you would say are, on
the evidence, associated with obesity - and this is
epidemiological evidence that we’re talking about,
isn’t it?
Yes. It’s epidemiological evidence often supported by
mechanistic studies - other studies using biomarkers in
humans or studies using experimental models in rodents. I
would say my short-list is based on a number of consensus
papers that have been published over the past year or two.Correspondence: e.riboli@imperial.ac.uk
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where after menopause is extremely important because there
is no increased risk of breast cancer before menopause
associated with obesity. If anything, overweight women
have a slightly reduced risk of developing breast cancer
during their reproductive life, or until when they enter into
menopause.
That’s very mystifying, is it not?
It is really, really a nightmare. Because the same results
were found in most of the North American cohorts and by
us in Europe. So observationally, if we just take the weight
of women who are in their 20s or 30s and we follow themis is an Open Access article distributed under the terms of the Creative
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at body mass index (BMI), it is quite clear that there is
a slight reduction of breast cancer incidence among
overweight and obese women, that is actually linearly
associated in more obese women. We are talking about
not a huge difference; we’re talking about a 10 to 15%
reduced incidence in overweight-obese women in the age
range 30 to 45/50.
And after menopause, how big is the difference?
Well, it reverses. I’d say a relative risk of 1.2, 1.4, anything
between 20 and 30% increased risk.
So not huge, again?
It’s not huge, but for a very highly prevalent cancer like
breast cancer - where 10 women out of 100 will develop
the cancer in their life in most European countries - it says
that probably 2 out of 10 of those cancers might be
prevented if women would not be overweight - if they
would stay on a BMI below 26. The other cancers that have
been consistently found at higher risk in overweight and
obese subjects are cancer of the colon and rectum, as well
as cancer of the endometrium - which is probably the
cancer which has the strongest association of all with
obesity - I would say it was even known 20 years ago that
obesity increases the risk of endometrial cancer, it doesn’t
matter at which age - at all possible ages. And another is
kidney cancer, where there is an increased risk in people
who are overweight and - to complicate things - in people
who have hypertension. This has been found in both
European and North American studies.
Finally, but it’s not trivial, there is a very clear association
of obesity with the adenocarcinoma of the oesophagus. I’m
sure you are familiar with the fact that oesophagus cancer
comes in two main types. One is called the squamous cell
carcinoma, which is strongly related to alcohol and tobacco
consumption. The other is the one that - when I started 20
or 30 years ago - was extremely rare in North America and
Europe: adenocarcinoma. Now, this adenocarcinoma of the
oesophagus, which represented maybe a maximum of 5% or
10% of the cases 30 years ago, now represents over 50% of
60% of the cases of oesophageal cancer in North America
and Europe. This is the one that, together with cancer of the
upper part of the stomach - called the cardia - it’s the upper
part of the stomach, close to the oesophageal connection -
these cancers, these adenocarcinomas, are associated with
obesity. There are very consistent results on this.
So to summarize, it’s breast post-menopausal, colorec-
tum, endometrium, kidney, and then adenocarcinoma
of the oesophagus and the cardia. There are limited
data, which give more conflicting results, regarding
aggressive advanced prostate cancer, for which some
studies found an association, but others don’t find an in-
creased risk. And a little bit more, let’s say, discordantresults for cancer of the pancreas. If, overall, one looks
at cancer mortality - as was done, for example, in
the follow-up of the huge American Cancer Society
cohort - what you see is that overall obesity is associ-
ated with overall increased mortality for cancer. But
it’s mainly due to these cancers.
Why should endometrial cancer be particularly
strongly associated with obesity?
Essentially, endometrial cancer is very strongly associ-
ated with estrogen levels. So we have published from
our EPIC study, and others have published from other
studies, data showing that there is a very strong associ-
ation: the higher the blood estrogen levels, the higher
the risk of endometrial cancer. The association is very,
very strong. Within what is called the ‘normal physio-
logical range’ of estrogen levels in blood, women with
the highest levels have increased risk of endometrial
cancer. It’s something like three- to four-fold.
Now, if then you look physiologically, what is abso-
lutely crystal clear is that BMI is linearly associated with
estrogen levels in the blood. So the more adipose tissue
there is, the more estrogens. The mechanism is very
well known, because adipose tissue is very rich in an
enzyme called aromatase. The aromatase converts
androgens into estrogens. Basically, the adipose tissue is
a very metabolically active tissue - contrary to what one
may think - and has this important property of produ-
cing estrogens.
So that fully explains that relationship?
It’s the main explanation of the relationship. The other
one is insulin resistance, which is the one that we have
been working on for more than a decade. Women who
are insulin resistant tend, obviously, to have higher
levels of insulin, because they need more insulin to use
their glucose. When blood levels of insulin go up, there
is a negative feedback on the liver production of a
globulin that has a very central role in regulating sex
hormones. It’s called sex hormone binding globulin -
SHBG.
The sex hormone binding globulin binds, in an active
form, estrogens and androgens and is down-regulated
by insulin. When people overeat and develop insulin re-
sistance, are overweight, and have low physical activity -
they tend to have high blood levels of insulin. Insulin
will then inhibit the liver production of sex hormone
binding globulin, and that will result in an increased
proportion of free estrogens and free androgens.
So there are two effects. One is that in the obese, the
adipose tissue produces estrogens, converts androgens
to estrogens. The second one is that insulin, down-
regulating sex hormone binding globulin, makes estro-
gen more bioavailable.
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in both cases?
Yes… and this is supported by metabolic and experimental
models.
That brings us to the question: if there is a clear
link between obesity and cancers of various
kinds, can they be prevented by diet and are
there any particular dietary items or is it just a
question of excessive intake of food?
That is actually the most difficult question to answer.
Certainly the component of cancer risk that is due to
obesity is the end result of what, in nutrition, we call
‘energy balance’, which is the balance between our energy
expenditure and our energy intake. So the effect is due to
obesity. But the research conducted over the past two
decades indicates that there is also - I would call it -
almost a separate parallel effect of the type of food, with
results that are quite well known in the scientific but also
in the lay press. Generally, consumption of red meat and
processed meat is associated with a modest but consist-
ently observed increased risk of developing cancer of the
colon and rectum, specifically. Consumption of fruit and
vegetables has a much weaker effect than we thought in
the past, but a diet rich in fruit and vegetable and with
relatively modest intake of red meat is generally associated
with a decreased risk of cancer of different types.
Now, if anything has changed over the past 10 years,
it’s that 10 years ago, if you had asked the same question
of me and many other colleagues, we would have said:
‘Well, the main association of cancer and nutrition is via
the type of food you eat’. Over the past decade, the
evidence of the association of the effect of obesity has
come up very, very strongly. And I should say - obesity
AND lack of physical activity, almost equally. This has
been a switch in our understanding of the relationship
between nutrition and cancer - the emerging role of
obesity and sedentary life.
That raises the crucial practical question of whether
there is any way that this can realistically be tackled,
in the way that smoking was tackled some decades
ago?
This is the nightmare question because clearly there has
been growing knowledge and understanding that -
whether it’s for cancer or diabetes or cardiovascular
diseases - obesity is not a good thing for health. Despite
widespread knowledge, there are impressive data on the
epidemic of obesity around the world [1,2] that show the
prevalence of obesity in many parts of the world continues
to increase. So whatever we are saying and whatever we
are trying to do is not working.
What we have is the knowledge that if you set up a
very intense weight loss program, people generallytend to lose weight. The big problem is that when
people are out of that program - after 6 months or
12 months, they’ve lost their few kilograms - weight
maintenance becomes the nightmare. Because people
lose weight and then progressively tend to come back
to the way that they were before. It’s the so-called
yo-yo function.
It’s a big challenge we have now from a public health
point of view, clearly. If you focus on just one individual,
you may win the battle. But when you think there are over
two billion people overweight or obese around the planet,
then it’s a serious matter.
Do you think there’s any hope?
Well, I don’t know. Having been in cancer epidemiology
for almost three decades now, I would say, I see where
we are with obesity now, with due, let’s say, prudence, is
where we were with smoking in the 1970s. Everybody
knew that smoking was bad. Everybody knew it was
bad, but people were smoking everywhere! In the
streets, in the restaurants, in the pubs, in the bars, in
the theatres.
People were smoking in hospitals. Hospitals! When my
first son was born, I spoke with the obstetrician and he had
a pack of Marlboro in his hand, and I said, ‘Don’t you
recommend pregnant women to stop smoking?’ And he
said: ‘But why should I?’
I’ll try to put a pinch of optimism in our conversation.
In the 1970s, we knew that smoking was really bad but
it looked like the tobacco industry was unbeatable. Now
we have come a long way. We’ve clearly shown that
smoking habits are really changing now, have dropped
enormously in Europe and North America and
Australia. So we can win the battle. Maybe it’s a little bit
like that now with obesity. The huge social class
gradient in obesity suggests that with education, with
better understanding of the risk factors and so on,
maybe it’s going to work. Because also smoking started
decreasing in the higher social class and then spread to
the entire society - I mean more and more people
started giving up smoking.
And also there was pressure back on the tobacco
companies. Would we not also have to tackle the
people who make popular high-sugar foods and
drinks?
Yes, I think certainly there are issues here as well.
Pressure for some sectors in the food industry that we
know extremely well promote foods which are very
rich in what we call the void calories - where there is
an excessive amount of sugar and fat, while the same
food could be produced in a more healthy way. Or
rather than sweet drinks, people may just drink
something else. Water, for example!
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high-carbohydrate, high-sugar foods that happened
to smoking?
I’ll be very happy to see that change in trend.
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